Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1308753

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1308753

Nerve Repair and Regeneration Market Forecasts to 2030 - Global Analysis By Product, Surgery, Application, End User and By Geography

PUBLISHED:
PAGES: 175+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $8.94 billion in 2023 and is expected to reach $22.52 billion by 2030 growing at a CAGR of 14.1% during the forecast period. Neurostimulation, neuromodulators, and biomaterial devices are among the products available for nerve repair and regeneration. These devices are used to treat traumatic or neurodegenerative diseases such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy. Because the brain, spinal cord, and peripheral nerves are delicate and readily damaged, they can impair the brain's capacity to communicate with muscles and organs. These damages are repaired by nerve repair and regeneration products.

According to the journal The Lancet Global Health published in July 2021, it was reported that around 50 million people suffer from epilepsy, globally. As per the same source, it was also reported that around 10-12 million people are diagnosed with epilepsy, in India.

Market Dynamics:

Driver:

Globally developing nations

Developing countries such as India, China, and Brazil are likely to provide market participants with substantial growth prospects over the projection period. The massive population base, particularly in India and China, is projected to be a big draw for enterprises approaching this market. This is aided by the increasing prevalence of neurological illnesses such as Alzheimer's, Parkinson's, and epilepsy. According to the World Bank, healthcare expenditure in these nations is increasing, which is supporting the rise of hospitals and ambulatory surgery facilities. As hospitals and ambulatory surgery centers are key end consumers of nerve repair and regeneration products, this is considered a good indicator for market expansion.

Restraint:

Uncertain clinical outcomes

Despite significant advances in neuropathophysiology and experimental indications of promising neurotherapies, obtaining clinical outcomes in cases of avulsion, crush, or blast injuries to peripheral nerves remains difficult. Although vigorous rehabilitation after a nerve injury may reduce the incidence of muscular disuse atrophy after a nerve transaction or trauma, denervation atrophy of muscle targets is a serious impediment to nerve regeneration initiatives. Even the best neuroregeneration outcomes can be harmed by the absence of a viable neuromuscular junction (NMJ) or muscle target, resulting in poor functional outcomes.

Opportunity:

Growth of geriatric population

The world's developed regions have witnessed a growth in the geriatric population. Neurologic illnesses such as stroke, neuropathy, Alzheimer's disease, and Parkinson's disease are more prevalent among the elderly population. Geriatrics make up a significant portion of the entire patient pool due to their higher susceptibility. As a result, the sustained and increased need for nerve repair and regeneration for the treatment of neurological illnesses will be ensured by the rise of this segment of the population.

Threat:

Neurostimulation and neuromodulation devices are expensive

The use of neuromodulation devices has a substantial upfront cost. Because of the high cost of these devices, they may be used disproportionately in geographical locations with varying levels of financial resources. While neurostimulation has a high up-front cost for patients and insurance companies, the costs to the nation's healthcare system from long-term concerns with the treatment are insignificant. Furthermore, insurance companies cover some but not all therapy. This has an impact on the hospital's overall budget. As a result, this element would have a considerable impact on the market.

COVID-19 Impact:

The COVID-19 epidemic had a detrimental influence on the nerve repair and regeneration market because hospital and healthcare services were drastically limited due to social distancing measures implemented by governments worldwide. Furthermore, the COVID-19 pandemic had a significant impact on the functioning of general hospital treatment for non-COVID-19 patients in hospitals around the world. The need for nerve repair and regeneration procedures is decreasing as many hospitals and clinics remain closed due to the lockdown.

The stem cell therapy segment is expected to be the largest during the forecast period:

Because of the increasing frequency of neurological illnesses as well as the growing desire for effective treatment alternatives, different government efforts, and approvals to perform research investigations of biomaterials, the Stem Cell Therapy segment is poised to hold the largest share throughout the projection period. Additionally, following differentiation, stem cells could be used to treat neurodegenerative illnesses by replacing defective, dead, or dying brain cells.

The hospitals segment is expected to have the highest CAGR during the forecast period:

The hospital segment commanded the highest CAGR throughout the projected period. The rising frequency of neurological illnesses, the increasing number of hospitals in developing countries, and the growth and development of neuroepidemiology have all been important driving factors in the hospital segment's rise. However, continuous monitoring is an outstanding approach that assists medical and nursing staff by providing more information about the patient's physiologic condition. As hospitals are the primary end-users of nerve repair and regeneration products, this is considered a favorable indicator for market growth.

Region with largest share:

During the forecast period, North America dominated the nerve repair and regeneration market share, owing to an increase in the prevalence of neurodegenerative and neurodevelopmental diseases, stroke, and traumatic brain injuries; an increase in the adoption of advanced healthcare infrastructure; and an increase in patient awareness of nerve repair and regeneration modalities. Furthermore, the presence of significant market competitors and frequent product developments in this area are projected to play an important role in market growth.

Region with highest CAGR:

Due to increased patient awareness, supportive government initiatives, the prevalence of unmet medical requirements, and the emergence of novel technologies, Asia-Pacific is expected to have the highest CAGR throughout the forecast period. Economic growth in this region's countries, the rising frequency of neurologic illnesses, the rising standard of living, the rising demand for outstanding medical care, and rising healthcare spending will drive the region's market throughout the projection period. Moreover, China, India, Japan, Australia, and Singapore are the primary contributors to the region's growth.

Key players in the market

Some of the key players in Nerve Repair and Regeneration market include Polyganics , Nevro Corp., Soterix Medical, Inc., Kerimedical, Livanova, Plc., Integra Lifesciences, Collagen Matrix, Inc., Axogen, Inc., Neuropace, Inc., Aleva Neurotherapeutics, Boston Scientific Corporation, Baxter International, Inc., Synapse Biomedical, Inc., Medtronic, Plc. and Abbott Laboratories.

Key Developments:

In October 2022, Phageneis received United States FDA de novo approval for the Phagenyx neurostimulation system, which uses pharyngeal electrical stimulation to restore swallowing control in patients with severe dysphagia post-stroke.

In August 2022, Abbott received United States FDA approval for the ProClaim plus spinal cord stimulation system featuring FlexBurst therapy. The next generation of Abbott's proprietary BurstDR stimulation, FlexBurst 360 therapy, offers pain coverage across six areas of the trunk and limbs.

Products Covered:

  • Biomaterials
  • Neurostimulation and Neuromodulation Devices
  • Other Products

Surgeries Covered:

  • Neuromodulation Surgery
  • Stem Cell Therapy
  • Nerve Grafting
  • Direct Neuropathy

Applications Covered:

  • Nerve Grafting
  • Neurostimulation and Neuromodulation Surgeries
  • Stem Cell Therapy
  • Direct Nerve Repair/Neurorrhaphy
  • Nerve Repair & Regeneration Biomaterials
  • Other Applications

End Users Covered:

  • Ambulatory Surgery Centers
  • Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC23453

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product

  • 5.1 Introduction
  • 5.2 Biomaterials
    • 5.2.1 Nerve Wraps
    • 5.2.2 Nerve Connectors
    • 5.2.3 Nerve Protectors
    • 5.2.4 Nerve Conduits
  • 5.3 Neurostimulation and Neuromodulation Devices
    • 5.3.1 Internal Neurostimulation Devices
      • 5.3.1.1 Sacral Nerve Stimulation (SNS)
      • 5.3.1.2 Deep Brain Stimulation (DBS)
      • 5.3.1.3 Vagus Nerve Stimulation (VNS)
      • 5.3.1.4 Spinal Cord Stimulation (SCS)
      • 5.3.1.5 Gastric Electrical Stimulation (GES)
    • 5.3.2 External Neurostimulation Devices
      • 5.3.2.1 Respiratory Electric Stimulation (RES) Devices
      • 5.3.2.2 Transcranial Magnetic Stimulation (TMS) Devices
      • 5.3.2.3 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 5.4 Other Products

6 Global Nerve Repair and Regeneration Market, By Surgery

  • 6.1 Introduction
  • 6.2 Neuromodulation Surgery
  • 6.3 Stem Cell Therapy
  • 6.4 Nerve Grafting
  • 6.5 Direct Neuropathy

7 Global Nerve Repair and Regeneration Market, By Application

  • 7.1 Introduction
  • 7.2 Nerve Grafting
    • 7.2.1 Xenografts
    • 7.2.2 Autografts
    • 7.2.3 Allografts
  • 7.3 Neurostimulation and Neuromodulation Surgeries
    • 7.3.1 Internal Neurostimulation and Neuromodulation Surgeries
    • 7.3.2 External Neurostimulation and Neuromodulation Surgeries
  • 7.4 Stem Cell Therapy
  • 7.5 Direct Nerve Repair/Neurorrhaphy
    • 7.5.1 Group Fascicular Repair
    • 7.5.2 Epineural Repair
    • 7.5.3 Perineural Repair
  • 7.6 Nerve Repair & Regeneration Biomaterials
    • 7.6.1 Direct Nerve Repair/Neurorrhaphy
      • 7.6.1.1 Group Fascicular Repair
      • 7.6.1.2 Perineural Repair
      • 7.6.1.3 Epineural Repair
  • 7.7 Other Applications

8 Global Nerve Repair and Regeneration Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgery Centers
  • 8.3 Clinics
  • 8.4 Hospitals
  • 8.5 Other End Users

9 Global Nerve Repair and Regeneration Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Polyganics
  • 11.2 Nevro Corp.
  • 11.3 Soterix Medical, Inc.
  • 11.4 Kerimedical
  • 11.5 Livanova, Plc.
  • 11.6 Integra Lifesciences
  • 11.7 Collagen Matrix, Inc.
  • 11.8 Axogen, Inc.
  • 11.9 Neuropace, Inc.
  • 11.10 Aleva Neurotherapeutics
  • 11.11 Boston Scientific Corporation
  • 11.12 Baxter International, Inc.
  • 11.13 Synapse Biomedical, Inc.
  • 11.14 Medtronic, Plc.
  • 11.15 Abbott Laboratories
Product Code: SMRC23453

List of Tables

  • Table 1 Global Nerve Repair and Regeneration Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Nerve Repair and Regeneration Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Nerve Repair and Regeneration Market Outlook, By Biomaterials (2021-2030) ($MN)
  • Table 4 Global Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2021-2030) ($MN)
  • Table 5 Global Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2021-2030) ($MN)
  • Table 6 Global Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2021-2030) ($MN)
  • Table 7 Global Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2021-2030) ($MN)
  • Table 8 Global Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2021-2030) ($MN)
  • Table 9 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2021-2030) ($MN)
  • Table 10 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2021-2030) ($MN)
  • Table 11 Global Nerve Repair and Regeneration Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Nerve Repair and Regeneration Market Outlook, By Surgery (2021-2030) ($MN)
  • Table 13 Global Nerve Repair and Regeneration Market Outlook, By Neuromodulation Surgery (2021-2030) ($MN)
  • Table 14 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2021-2030) ($MN)
  • Table 15 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2021-2030) ($MN)
  • Table 16 Global Nerve Repair and Regeneration Market Outlook, By Direct Neuropathy (2021-2030) ($MN)
  • Table 17 Global Nerve Repair and Regeneration Market Outlook, By Application (2021-2030) ($MN)
  • Table 18 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2021-2030) ($MN)
  • Table 19 Global Nerve Repair and Regeneration Market Outlook, By Xenografts (2021-2030) ($MN)
  • Table 20 Global Nerve Repair and Regeneration Market Outlook, By Autografts (2021-2030) ($MN)
  • Table 21 Global Nerve Repair and Regeneration Market Outlook, By Allografts (2021-2030) ($MN)
  • Table 22 Global Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2021-2030) ($MN)
  • Table 23 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2021-2030) ($MN)
  • Table 24 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2021-2030) ($MN)
  • Table 25 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2021-2030) ($MN)
  • Table 26 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2021-2030) ($MN)
  • Table 27 Global Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2021-2030) ($MN)
  • Table 28 Global Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2021-2030) ($MN)
  • Table 29 Global Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2021-2030) ($MN)
  • Table 30 Global Nerve Repair and Regeneration Market Outlook, By Nerve Repair & Regeneration Biomaterials (2021-2030) ($MN)
  • Table 31 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2021-2030) ($MN)
  • Table 32 Global Nerve Repair and Regeneration Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 33 Global Nerve Repair and Regeneration Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 Global Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 35 Global Nerve Repair and Regeneration Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 36 Global Nerve Repair and Regeneration Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 Global Nerve Repair and Regeneration Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!